Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.4.2 and the previous government-funding status notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check20 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page version updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older QC label capitalization and the 'No FEAR Act Data' notices.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing the HHS Vulnerability Disclosure link and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedPage footer revision label updated from v3.2.0 to v3.3.2; no study content or functionality appears affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.